The ubiquity of GLP-1 drugs for weight management is changing the landscape of the supplements industry. Case in point: till now, maintaining muscle mass was not near the top of most people’s health care concerns. In the GLP-1 era , with muscle mass loss cited as one its main drawbacks, maintaining muscle mass and addressing related health issues has become front and center – particularly for women and seniors. Similarly, post-GLP-1 regimens are gaining attention with the specter of rapid weight gain in play. This webinar will focus on strategies to develop supplement solutions that address muscle mass loss, mobility and post-treatment weight gain related to GLP-1 drugs.

Steve Fink
Vice President, Marketing
PLT Health Solutions

Dr. Jeremy Appleton
Director of Medical and Scientific Affairs
PLT Health Solutions

Brett Bernier
Director of Sports & Active Nutrition
PLT Health Solutions

Sean Moloughney
Moderator, Editor
Nutraceuticals World